DESMOTABS

This brand name is authorized in Ireland, Malta, United Kingdom

Active ingredients

The drug DESMOTABS contains one active pharmaceutical ingredient (API):

1 Desmopressin UNII ENR1LLB0FP - DESMOPRESSIN

Desmopressin is a structural analogue of vasopressin in which the antidiuretic activity has been enhanced by the order of 10, while the vasopressor effect has been reduced by the order of 1500. The clinical advantage of this highly changed ratio of antidiuretic to vasopressor effect is that clinically active antidiuretic doses are far below the threshold for a vasopressor effect. Read about Desmopressin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DESMOTABS Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H01BA02	Desmopressin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01B Posterior pituitary lobe hormones → H01BA Vasopressin and analogues
Discover more medicines within H01BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 26771
Country: IE	Health Products Regulatory Authority	Identifier(s): 13410, 20853, 22001, 22007
Country: MT	Medicines Authority	Identifier(s): MA1314/00504